Solventum (SOLV) Financials

$66.14 -1.39 (-2.06%)

Closing price 04/25/2025 03:59 PM Eastern

Extended Trading

$66.70 +0.56 (+0.85%)

As of 04/25/2025 06:15 PM Eastern

Annual Income Statements for Solventum

This table shows Solventum's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Net Income / (Loss) Attributable to Common Shareholders	1,343	1,346	479
Consolidated Net Income / (Loss)	1,343	1,346	479
Net Income / (Loss) Continuing Operations	1,343	1,346	478
Total Pre-Tax Income	1,692	1,667	605
Total Operating Income	1,693	1,692	1,036
Total Gross Profit	4,695	4,693	4,593
Total Revenue	8,130	8,197	8,254
Operating Revenue	8,130	8,197	8,254
Total Cost of Revenue	3,435	3,504	3,661
Operating Cost of Revenue	3,435	3,504	3,661
Total Operating Expenses	3,002	3,001	3,557
Selling, General & Admin Expense	2,235	2,243	2,782
Research & Development Expense	767	758	775
Total Other Income / (Expense), net	-1.00	-25	-431
Interest & Investment Income	0.00	0.00	-367
Other Income / (Expense), net	-1.00	-25	-64
Income Tax Expense	349	321	127
Basic Earnings per Share	$7.78	$7.79	$2.77
Weighted Average Basic Shares Outstanding	172.70M	172.70M	173.20M
Diluted Earnings per Share	$7.78	$7.79	$2.76
Weighted Average Diluted Shares Outstanding	172.70M	172.70M	173.70M
Weighted Average Basic & Diluted Shares Outstanding	-	-	172.99M

This table shows Solventum's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Income / (Loss) Attributable to Common Shareholders	293	321	460	272	237	89	122	31
Consolidated Net Income / (Loss)	293	321	460	272	237	89	122	31
Net Income / (Loss) Continuing Operations	293	321	460	272	237	89	122	30
Total Pre-Tax Income	363	413	500	391	329	96	167	13
Total Operating Income	365	417	504	406	381	244	275	136
Total Gross Profit	1,137	1,189	1,209	1,158	1,172	1,137	1,165	1,119
Total Revenue	2,011	2,076	2,074	2,036	2,016	2,081	2,082	2,075
Operating Revenue	2,011	2,076	2,074	2,036	2,016	2,081	2,082	2,075
Total Cost of Revenue	874	887	865	878	844	944	917	956
Operating Cost of Revenue	874	887	865	878	844	944	917	956
Total Operating Expenses	772	772	705	752	791	893	890	983
Selling, General & Admin Expense	577	579	525	562	596	701	701	784
Research & Development Expense	195	193	180	190	195	192	189	199
Total Other Income / (Expense), net	-2.00	-4.00	-4.00	-15	-52	-148	-108	-123
Interest & Investment Income	0.00	0.00	0.00	-	-39	-114	-107	-107
Other Income / (Expense), net	-2.00	-4.00	-4.00	-15	-13	-34	-1.00	-16
Income Tax Expense	70	92	40	119	92	7.00	45	-17
Basic Earnings per Share	$1.70	$1.86	$2.66	$1.57	$1.37	$0.51	$0.70	$0.19
Weighted Average Basic Shares Outstanding	172.70M	172.70M	172.70M	172.70M	172.70M	173.20M	173.40M	173.20M
Diluted Earnings per Share	$1.70	$1.86	$2.66	$1.57	$1.37	$0.51	$0.70	$0.18
Weighted Average Diluted Shares Outstanding	172.70M	172.70M	172.70M	172.70M	172.70M	173.50M	173.90M	173.70M
Weighted Average Basic & Diluted Shares Outstanding	-	-	-	0.00	172.71M	172.71M	172.75M	172.99M

This table details how cash moves in and out of Solventum's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Net Change in Cash & Equivalents	-30	133	568
Net Cash From Operating Activities	1,679	1,915	1,185
Net Cash From Continuing Operating Activities	1,679	1,915	1,185
Net Income / (Loss) Continuing Operations	1,343	1,346	479
Consolidated Net Income / (Loss)	1,343	1,346	479
Depreciation Expense	578	561	555
Non-Cash Adjustments To Reconcile Net Income	101	24	-419
Changes in Operating Assets and Liabilities, net	-343	-16	570
Net Cash From Investing Activities	-253	-230	-380
Net Cash From Continuing Investing Activities	-253	-230	-380
Purchase of Property, Plant & Equipment	-251	-290	-380
Divestitures	0.00	60	0.00
Other Investing Activities, net	-2.00	0.00	0.00
Net Cash From Financing Activities	-1,460	-1,552	-240
Net Cash From Continuing Financing Activities	-1,460	-1,552	-240
Repayment of Debt	-4.00	1.00	-292
Issuance of Debt	0.00	0.00	8,303
Other Financing Activities, net	-1,456	-1,553	-8,251
Effect of Exchange Rate Changes	4.00	0.00	3.00
Cash Interest Paid	0.00	0.00	287
Cash Income Taxes Paid	0.00	0.00	244

This table details how cash moves in and out of Solventum's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Change in Cash & Equivalents	-18	-4.00	3.00	152	802	-99	-125	-10
Net Cash From Operating Activities	509	366	493	547	442	355	169	219
Net Cash From Continuing Operating Activities	509	366	493	547	442	355	169	219
Net Income / (Loss) Continuing Operations	293	321	460	272	237	89	122	31
Consolidated Net Income / (Loss)	293	321	460	272	237	89	122	31
Depreciation Expense	145	133	144	139	139	133	133	150
Non-Cash Adjustments To Reconcile Net Income	28	19	-40	17	13	-163	-126	-143
Changes in Operating Assets and Liabilities, net	43	-107	-71	119	53	296	40	181
Net Cash From Investing Activities	-65	-71	-6.00	-88	-102	-58	-93	-127
Net Cash From Continuing Investing Activities	-65	-71	-6.00	-88	-102	-58	-93	-127
Purchase of Property, Plant & Equipment	-65	-71	-66	-88	-102	-58	-93	-127
Net Cash From Financing Activities	-462	-299	-485	-306	462	-396	-202	-104
Net Cash From Continuing Financing Activities	-462	-299	-485	-306	462	-396	-202	-104
Repayment of Debt	-2.00	2.00	2.00	-1.00	10	-	-202	-100
Other Financing Activities, net	-460	-301	-487	-305	-7,851	-396	-	-4.00
Effect of Exchange Rate Changes	0.00	-	1.00	-1.00	0.00	-	1.00	2.00

This table presents Solventum's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2023	2024
Total Assets	13,943	14,457
Total Current Assets	2,519	3,249
Cash & Equivalents	194	762
Accounts Receivable	1,313	1,229
Inventories, net	857	965
Other Current Assets	155	293
Plant, Property, & Equipment, net	1,457	1,622
Total Noncurrent Assets	9,967	9,586
Goodwill	6,535	6,377
Intangible Assets	2,902	2,544
Other Noncurrent Operating Assets	530	665
Total Liabilities & Shareholders' Equity	13,943	14,457
Total Liabilities	2,277	11,498
Total Current Liabilities	1,728	2,703
Short-Term Debt	0.00	200
Accounts Payable	477	618
Accrued Expenses	0.00	272
Current Deferred Revenue	574	572
Other Current Liabilities	677	1,041
Total Noncurrent Liabilities	549	8,795
Long-Term Debt	0.00	7,810
Noncurrent Deferred & Payable Income Tax Liabilities	231	225
Noncurrent Employee Benefit Liabilities	166	350
Other Noncurrent Operating Liabilities	152	410
Commitments & Contingencies	0.00	0.00
Total Equity & Noncontrolling Interests	11,666	2,959
Total Preferred & Common Equity	11,666	2,959
Total Common Equity	11,666	2,959
Common Stock	0.00	3,773
Retained Earnings	0.00	242
Accumulated Other Comprehensive Income / (Loss)	-337	-1,056
Other Equity Adjustments	12,003	0.00

This table presents Solventum's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Total Assets	13,943	14,711	14,578	14,745	14,457
Total Current Assets	2,519	3,359	3,363	3,354	3,249
Cash & Equivalents	194	996	897	772	762
Accounts Receivable	1,313	1,220	1,317	1,327	1,229
Inventories, net	857	901	899	953	965
Other Current Assets	155	242	250	302	293
Plant, Property, & Equipment, net	1,457	1,491	1,537	1,599	1,622
Total Noncurrent Assets	9,967	9,861	9,678	9,792	9,586
Goodwill	6,535	6,468	6,447	6,592	6,377
Intangible Assets	2,902	2,810	2,724	2,651	2,544
Other Noncurrent Operating Assets	530	583	507	549	665
Total Liabilities & Shareholders' Equity	13,943	14,711	14,578	14,745	14,457
Total Liabilities	2,277	10,860	11,711	11,553	11,498
Total Current Liabilities	1,728	1,854	2,571	2,904	2,703
Short-Term Debt	0.00	-	-	300	200
Accounts Payable	477	587	495	560	618
Accrued Expenses	0.00	-	611	450	272
Current Deferred Revenue	574	566	505	563	572
Other Current Liabilities	677	701	960	1,031	1,041
Total Noncurrent Liabilities	549	9,006	9,140	8,649	8,795
Long-Term Debt	0.00	8,303	8,306	7,809	7,810
Noncurrent Deferred & Payable Income Tax Liabilities	231	211	214	214	225
Noncurrent Employee Benefit Liabilities	166	321	315	321	350
Other Noncurrent Operating Liabilities	152	171	305	305	410
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	11,666	3,851	2,867	3,192	2,959
Total Preferred & Common Equity	11,666	3,851	2,867	3,192	2,959
Total Common Equity	11,666	3,851	2,867	3,192	2,959
Common Stock	0.00	-	3,721	3,746	3,773
Retained Earnings	0.00	-	89	211	242
Accumulated Other Comprehensive Income / (Loss)	-337	-958	-943	-765	-1,056
Other Equity Adjustments	12,003	4,809	0.00	0.00	0.00

This table displays calculated financial ratios and metrics derived from Solventum's official financial filings.

Metric	2022	2023	2024
Growth Metrics	-	-	-
Revenue Growth	0.00%	0.82%	0.70%
EBITDA Growth	0.00%	-1.85%	-31.46%
EBIT Growth	0.00%	-1.48%	-41.69%
NOPAT Growth	0.00%	1.67%	-40.09%
Net Income Growth	0.00%	0.22%	-64.41%
EPS Growth	0.00%	0.13%	-64.57%
Operating Cash Flow Growth	0.00%	14.06%	-38.12%
Free Cash Flow Firm Growth	0.00%	0.00%	120.62%
Invested Capital Growth	0.00%	0.00%	-11.03%
Revenue Q/Q Growth	0.00%	0.00%	0.00%
EBITDA Q/Q Growth	0.00%	0.00%	0.00%
EBIT Q/Q Growth	0.00%	0.00%	0.00%
NOPAT Q/Q Growth	0.00%	0.00%	0.00%
Net Income Q/Q Growth	0.00%	0.00%	0.00%
EPS Q/Q Growth	0.00%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	0.00%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	0.00%	0.00%	-3.06%
Profitability Metrics	-	-	-
Gross Margin	57.75%	57.25%	55.65%
EBITDA Margin	27.92%	27.18%	18.50%
Operating Margin	20.82%	20.64%	12.55%
EBIT Margin	20.81%	20.34%	11.78%
Profit (Net Income) Margin	16.52%	16.42%	5.80%
Tax Burden Percent	79.37%	80.74%	79.17%
Interest Burden Percent	100.00%	100.00%	62.24%
Effective Tax Rate	20.63%	19.26%	20.99%
Return on Invested Capital (ROIC)	0.00%	23.82%	7.55%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	44.63%	-2.08%
Return on Net Nonoperating Assets (RNNOA)	0.00%	-0.74%	-1.00%
Return on Equity (ROE)	0.00%	23.08%	6.55%
Cash Return on Invested Capital (CROIC)	0.00%	-176.18%	19.22%
Operating Return on Assets (OROA)	0.00%	11.96%	6.85%
Return on Assets (ROA)	0.00%	9.65%	3.37%
Return on Common Equity (ROCE)	0.00%	23.08%	6.55%
Return on Equity Simple (ROE_SIMPLE)	0.00%	11.54%	16.19%
Net Operating Profit after Tax (NOPAT)	1,344	1,366	819
NOPAT Margin	16.53%	16.67%	9.92%
Net Nonoperating Expense Percent (NNEP)	0.00%	-20.81%	9.63%
Return On Investment Capital (ROIC_SIMPLE)	-	11.71%	7.46%
Cost of Revenue to Revenue	42.25%	42.75%	44.35%
SG&A Expenses to Revenue	27.49%	27.36%	33.70%
R&D to Revenue	9.43%	9.25%	9.39%
Operating Expenses to Revenue	36.93%	36.61%	43.09%
Earnings before Interest and Taxes (EBIT)	1,692	1,667	972
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	2,270	2,228	1,527
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	0.00	0.00	3.86
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.00	0.00	1.38
Price to Earnings (P/E)	0.00	0.00	23.82
Dividend Yield	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	4.20%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	1.83
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	2.26
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	12.22
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	19.20
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	22.80
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	15.75
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	8.96
Leverage & Solvency	-	-	-
Debt to Equity	0.00	0.00	2.71
Long-Term Debt to Equity	0.00	0.00	2.64
Financial Leverage	0.00	-0.02	0.48
Leverage Ratio	0.00	1.20	1.94
Compound Leverage Factor	0.00	1.20	1.21
Debt to Total Capital	0.00%	0.00%	73.02%
Short-Term Debt to Total Capital	0.00%	0.00%	1.82%
Long-Term Debt to Total Capital	0.00%	0.00%	71.20%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%
Common Equity to Total Capital	0.00%	100.00%	26.98%
Debt to EBITDA	0.00	0.00	5.25
Net Debt to EBITDA	0.00	0.00	4.75
Long-Term Debt to EBITDA	0.00	0.00	5.11
Debt to NOPAT	0.00	0.00	9.79
Net Debt to NOPAT	0.00	0.00	8.85
Long-Term Debt to NOPAT	0.00	0.00	9.54
Altman Z-Score	0.00	0.00	1.46
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-
Current Ratio	0.00	1.46	1.20
Quick Ratio	0.00	0.87	0.74
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-10,106	2,084
Operating Cash Flow to CapEx	668.92%	660.34%	311.84%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00
Efficiency Ratios	-	-	-
Asset Turnover	0.00	0.59	0.58
Accounts Receivable Turnover	0.00	6.24	6.49
Inventory Turnover	0.00	4.09	4.02
Fixed Asset Turnover	0.00	5.63	5.36
Accounts Payable Turnover	0.00	7.35	6.69
Days Sales Outstanding (DSO)	0.00	58.47	56.20
Days Inventory Outstanding (DIO)	0.00	89.27	90.83
Days Payable Outstanding (DPO)	0.00	49.69	54.59
Cash Conversion Cycle (CCC)	0.00	98.05	92.45
Capital & Investment Metrics	-	-	-
Invested Capital	0.00	11,472	10,207
Invested Capital Turnover	0.00	1.43	0.76
Increase / (Decrease) in Invested Capital	0.00	11,472	-1,265
Enterprise Value (EV)	0.00	0.00	18,660
Market Capitalization	0.00	0.00	11,412
Book Value per Share	$0.00	$67.55	$17.13
Tangible Book Value per Share	$0.00	$12.91	($34.51)
Total Capital	0.00	11,666	10,969
Total Debt	0.00	0.00	8,010
Total Long-Term Debt	0.00	0.00	7,810
Net Debt	0.00	-194	7,248
Capital Expenditures (CapEx)	251	290	380
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	597	-16
Debt-free Net Working Capital (DFNWC)	0.00	791	746
Net Working Capital (NWC)	0.00	791	546
Net Nonoperating Expense (NNE)	0.79	20	340
Net Nonoperating Obligations (NNO)	0.00	-194	7,248
Total Depreciation and Amortization (D&A)	578	561	555
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	7.28%	-0.19%
Debt-free Net Working Capital to Revenue	0.00%	9.65%	9.04%
Net Working Capital to Revenue	0.00%	9.65%	6.62%
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	$2.77
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	173.20M
Adjusted Diluted Earnings per Share	$0.00	$0.00	$2.76
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	173.70M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	172.99M
Normalized Net Operating Profit after Tax (NOPAT)	1,344	1,366	819
Normalized NOPAT Margin	16.53%	16.67%	9.92%
Pre Tax Income Margin	20.81%	20.34%	7.33%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00
Payout Ratios	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Solventum's official financial filings.

Metric	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Growth Metrics	-	-	-	-	-	-	-	-
Revenue Growth	0.00%	0.00%	0.00%	0.00%	0.25%	0.24%	0.39%	1.92%
EBITDA Growth	0.00%	0.00%	0.00%	0.00%	-0.20%	-37.18%	-36.80%	-49.06%
EBIT Growth	0.00%	0.00%	0.00%	0.00%	1.38%	-49.15%	-45.20%	-69.31%
NOPAT Growth	0.00%	0.00%	0.00%	0.00%	-6.84%	-30.21%	-56.67%	11.12%
Net Income Growth	0.00%	0.00%	0.00%	0.00%	-19.11%	-72.27%	-73.48%	-88.60%
EPS Growth	0.00%	0.00%	0.00%	0.00%	-19.41%	-72.58%	-73.68%	-88.54%
Operating Cash Flow Growth	0.00%	0.00%	0.00%	0.00%	-13.16%	-3.01%	-65.72%	-59.96%
Free Cash Flow Firm Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Invested Capital Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-11.03%
Revenue Q/Q Growth	0.00%	3.23%	-0.10%	-1.83%	0.00%	3.22%	0.05%	-0.34%
EBITDA Q/Q Growth	0.00%	7.48%	17.95%	-17.70%	0.00%	-32.35%	18.66%	-33.66%
EBIT Q/Q Growth	0.00%	13.77%	21.07%	-21.80%	0.00%	-42.93%	30.48%	-56.20%
NOPAT Q/Q Growth	0.00%	10.01%	43.06%	-39.09%	0.00%	-17.58%	-11.19%	56.22%
Net Income Q/Q Growth	0.00%	9.56%	43.30%	-40.87%	0.00%	-62.45%	37.08%	-74.59%
EPS Q/Q Growth	0.00%	9.41%	43.01%	-40.98%	0.00%	-62.77%	37.25%	-74.29%
Operating Cash Flow Q/Q Growth	0.00%	-28.09%	34.70%	10.95%	0.00%	-19.68%	-52.39%	29.59%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	7.66%	-2.77%	115.29%
Invested Capital Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	-7.90%	2.46%	-3.06%
Profitability Metrics	-	-	-	-	-	-	-	-
Gross Margin	56.54%	57.27%	58.29%	56.88%	58.13%	54.64%	55.96%	53.93%
EBITDA Margin	25.26%	26.30%	31.05%	26.03%	25.15%	16.48%	19.55%	13.01%
Operating Margin	18.15%	20.09%	24.30%	19.94%	18.90%	11.73%	13.21%	6.55%
EBIT Margin	18.05%	19.89%	24.11%	19.20%	18.25%	10.09%	13.16%	5.78%
Profit (Net Income) Margin	14.57%	15.46%	22.18%	13.36%	11.76%	4.28%	5.86%	1.49%
Tax Burden Percent	80.72%	77.72%	92.00%	69.57%	72.04%	92.71%	73.05%	238.46%
Interest Burden Percent	100.00%	100.00%	100.00%	100.00%	89.40%	45.71%	60.95%	10.83%
Effective Tax Rate	19.28%	22.28%	8.00%	30.43%	27.96%	7.29%	26.95%	-130.77%
Return on Invested Capital (ROIC)	0.00%	0.00%	0.00%	9.91%	0.00%	0.00%	0.00%	11.52%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	0.00%	15.29%	0.00%	0.00%	0.00%	3.50%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	0.00%	-0.25%	0.00%	0.00%	0.00%	1.69%
Return on Equity (ROE)	0.00%	0.00%	0.00%	9.66%	0.00%	0.00%	0.00%	13.20%
Cash Return on Invested Capital (CROIC)	0.00%	0.00%	0.00%	-88.09%	0.00%	0.00%	0.00%	19.22%
Operating Return on Assets (OROA)	0.00%	0.00%	0.00%	11.29%	0.00%	0.00%	0.00%	3.36%
Return on Assets (ROA)	0.00%	0.00%	0.00%	7.85%	0.00%	0.00%	0.00%	0.87%
Return on Common Equity (ROCE)	0.00%	0.00%	0.00%	9.66%	0.00%	0.00%	0.00%	13.20%
Return on Equity Simple (ROE_SIMPLE)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	295	324	464	282	274	226	201	314
NOPAT Margin	14.65%	15.61%	22.36%	13.87%	13.61%	10.87%	9.65%	15.13%
Net Nonoperating Expense Percent (NNEP)	0.00%	0.00%	0.00%	-5.38%	1.03%	3.70%	2.15%	8.02%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	2.42%	-	-	-	2.86%
Cost of Revenue to Revenue	43.46%	42.73%	41.71%	43.12%	41.87%	45.36%	44.04%	46.07%
SG&A Expenses to Revenue	28.69%	27.89%	25.31%	27.60%	29.56%	33.69%	33.67%	37.78%
R&D to Revenue	9.70%	9.30%	8.68%	9.33%	9.67%	9.23%	9.08%	9.59%
Operating Expenses to Revenue	38.39%	37.19%	33.99%	36.94%	39.24%	42.91%	42.75%	47.37%
Earnings before Interest and Taxes (EBIT)	363	413	500	391	368	210	274	120
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	508	546	644	530	507	343	407	270
Valuation Ratios	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	0.00	0.00	3.19	3.77	3.86
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.38
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	23.82
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	4.20%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.00	0.00	0.00	1.61	1.84	1.83
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	2.26
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	12.22
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	19.20
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	22.80
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	15.75
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	8.96
Leverage & Solvency	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	2.16	2.90	2.54	2.71
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	2.16	2.90	2.45	2.64
Financial Leverage	0.00	0.00	0.00	-0.02	1.90	2.58	2.30	0.48
Leverage Ratio	0.00	0.00	0.00	1.20	3.82	5.08	4.62	1.94
Compound Leverage Factor	0.00	0.00	0.00	1.20	3.42	2.32	2.82	0.21
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	68.32%	74.34%	71.75%	73.02%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	2.65%	1.82%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	68.32%	74.34%	69.10%	71.20%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	0.00%	0.00%	0.00%	100.00%	31.69%	25.66%	28.25%	26.98%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	5.25
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	4.75
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	5.11
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	9.79
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	8.85
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	9.54
Altman Z-Score	0.00	0.00	0.00	0.00	0.00	0.59	0.74	1.26
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-
Current Ratio	0.00	0.00	0.00	1.46	1.81	1.31	1.16	1.20
Quick Ratio	0.00	0.00	0.00	0.87	1.20	0.86	0.72	0.74
Cash Flow Metrics	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	0.00	0.00	0.00	-10,884	-10,050	-10,328	1,579
Operating Cash Flow to CapEx	783.08%	515.49%	746.97%	621.59%	433.33%	612.07%	181.72%	172.44%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-
Asset Turnover	0.00	0.00	0.00	0.59	0.00	0.00	0.00	0.58
Accounts Receivable Turnover	0.00	0.00	0.00	6.24	0.00	0.00	0.00	6.49
Inventory Turnover	0.00	0.00	0.00	4.09	0.00	0.00	0.00	4.02
Fixed Asset Turnover	0.00	0.00	0.00	5.63	0.00	0.00	0.00	5.36
Accounts Payable Turnover	0.00	0.00	0.00	7.35	0.00	0.00	0.00	6.69
Days Sales Outstanding (DSO)	0.00	0.00	0.00	58.47	0.00	0.00	0.00	56.20
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	89.27	0.00	0.00	0.00	90.83
Days Payable Outstanding (DPO)	0.00	0.00	0.00	49.69	0.00	0.00	0.00	54.59
Cash Conversion Cycle (CCC)	0.00	0.00	0.00	98.05	0.00	0.00	0.00	92.45
Capital & Investment Metrics	-	-	-	-	-	-	-	-
Invested Capital	0.00	0.00	0.00	11,472	11,158	10,276	10,529	10,207
Invested Capital Turnover	0.00	0.00	0.00	0.71	0.00	0.00	0.00	0.76
Increase / (Decrease) in Invested Capital	0.00	0.00	0.00	0.00	11,158	10,276	10,529	-1,265
Enterprise Value (EV)	0.00	0.00	0.00	0.00	0.00	16,542	19,378	18,660
Market Capitalization	0.00	0.00	0.00	0.00	0.00	9,133	12,041	11,412
Book Value per Share	$0.00	$0.00	$0.00	$67.55	$22.30	$16.60	$18.48	$17.13
Tangible Book Value per Share	$0.00	$0.00	$0.00	$12.91	($31.42)	($36.50)	($35.04)	($34.51)
Total Capital	0.00	0.00	0.00	11,666	12,154	11,173	11,301	10,969
Total Debt	0.00	0.00	0.00	0.00	8,303	8,306	8,109	8,010
Total Long-Term Debt	0.00	0.00	0.00	0.00	8,303	8,306	7,809	7,810
Net Debt	0.00	0.00	0.00	-194	7,307	7,409	7,337	7,248
Capital Expenditures (CapEx)	65	71	66	88	102	58	93	127
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	0.00	0.00	597	509	-105	-22	-16
Debt-free Net Working Capital (DFNWC)	0.00	0.00	0.00	791	1,505	792	750	746
Net Working Capital (NWC)	0.00	0.00	0.00	791	1,505	792	450	546
Net Nonoperating Expense (NNE)	1.61	3.11	3.68	10	37	137	79	283
Net Nonoperating Obligations (NNO)	0.00	0.00	0.00	-194	7,307	7,409	7,337	7,248
Total Depreciation and Amortization (D&A)	145	133	144	139	139	133	133	150
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	0.00%	0.00%	7.28%	0.00%	0.00%	0.00%	-0.19%
Debt-free Net Working Capital to Revenue	0.00%	0.00%	0.00%	9.65%	0.00%	0.00%	0.00%	9.04%
Net Working Capital to Revenue	0.00%	0.00%	0.00%	9.65%	0.00%	0.00%	0.00%	6.62%
Earnings Adjustments	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	$0.00	$1.57	$1.37	$0.51	$0.70	$0.19
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	0.00	172.70M	172.70M	173.20M	173.40M	173.20M
Adjusted Diluted Earnings per Share	$0.00	$0.00	$0.00	$1.57	$1.37	$0.51	$0.70	$0.18
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	0.00	172.70M	172.70M	173.50M	173.90M	173.70M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	0.00	0.00	172.71M	172.71M	172.75M	172.99M
Normalized Net Operating Profit after Tax (NOPAT)	295	324	464	282	274	226	201	95
Normalized NOPAT Margin	14.65%	15.61%	22.36%	13.87%	13.61%	10.87%	9.65%	4.59%
Pre Tax Income Margin	18.05%	19.89%	24.11%	19.20%	16.32%	4.61%	8.02%	0.63%
Debt Service Ratios	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions About Solventum's Financials

When does Solventum's financial year end?

According to the most recent income statement we have on file, Solventum's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Solventum's net income changed over the last 2 years?

Solventum's net income appears to be on a downward trend, with a most recent value of $479 million in 2024, falling from $1.34 billion in 2022. The previous period was $1.35 billion in 2023.

What is Solventum's operating income?

Solventum's total operating income in 2024 was $1.04 billion, based on the following breakdown:

Total Gross Profit: $4.59 billion
Total Operating Expenses: $3.56 billion

How has Solventum revenue changed over the last 2 years?

Over the last 2 years, Solventum's total revenue changed from $8.13 billion in 2022 to $8.25 billion in 2024, a change of 1.5%.

How much debt does Solventum have?

Solventum's total liabilities were at $11.50 billion at the end of 2024, a 405.0% increase from 2023, and a 405.0% increase since 2023.

How much cash does Solventum have?

In the past 1 years, Solventum's cash and equivalents has ranged from $194 million in 2023 to $762 million in 2024, and is currently $762 million as of their latest financial filing in 2024.

How has Solventum's book value per share changed over the last 2 years?

Over the last 2 years, Solventum's book value per share changed from 0.00 in 2022 to 17.13 in 2024, a change of 1,712.8%.

Related Companies

This page (NYSE:SOLV) was last updated on 4/26/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Solventum (SOLV) Financials

Frequently Asked Questions About Solventum's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Solventum (SOLV) Financials

Annual Income Statements for Solventum

Quarterly Income Statements for Solventum

Annual Cash Flow Statements for Solventum

Quarterly Cash Flow Statements for Solventum

Annual Balance Sheets for Solventum

Quarterly Balance Sheets for Solventum

Annual Metrics and Ratios for Solventum

Quarterly Metrics and Ratios for Solventum

Frequently Asked Questions About Solventum's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools